Accu-Chek A1C Hemoglobin Test
Assay, Glycosylated Hemoglobin. 510(k) K974491, from Boehringer Mannheim Corp. (Indianapolis, IN). Product code LCP, class 2.
As of Nov 19, 2026, K974491 is an FDA 510(k) held by Boehringer Mannheim Corp., substantially equivalent on May 13, 1998 after 166 days, with no recalls tied to it in FDA's recall database.
- Review time: 166 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Accu-Chek A_{1c}^{TM Hemoglobin Test is designed for use with BMC Hitachi reagents that measure glycosylated hemoglobin. The test has not been evaluated using any other methodology. The device is intended for at-home or in-office use to collect a whole blood sample. The product will be marketed
- Tina-Quant Hemoglobin A1CK934070 · Boehringer Mannheim Corp. · Oct 11, 1994
- Ezchek/Hba Blood Collection KitK971919 · Flexsite Diagnostics, Inc. · Sep 5, 1997
- Precision A1C Home HBA1C Sample Collection KitK983253 · Medisense, Inc. · Nov 20, 1998
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 28, 1997
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files